“The contemporary approaches in the industry offer an interesting paradox of access to plethora of data coupled with advanced analytical techniques. However, those datasets live in silos, often in non-analyzable-ready formats denying the end user the ability to leverage advances in analytical techniques to get deep insights and to perform rapid “on the fly if-then” analysis to make critical decisions that have an impact on key outcomes of protocol design and siteselection. This conundrum needs a new approach to solve this vexing problem.
A unique way to disrupt this status quo is to leverage a “platform based” approach.”
Read more about how a platform-based approach can provide valuable data insights for clinical trials.